<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/58BA3BFC-AB13-4C69-8805-D8E3977BB4F9"><gtr:id>58BA3BFC-AB13-4C69-8805-D8E3977BB4F9</gtr:id><gtr:name>Nano Products</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3E738724-57DB-4CBB-A956-1F7720D9E193"><gtr:id>3E738724-57DB-4CBB-A956-1F7720D9E193</gtr:id><gtr:name>Invitron</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2E17EDA5-15D9-492E-BBC9-96F9CFC3A3DB"><gtr:id>2E17EDA5-15D9-492E-BBC9-96F9CFC3A3DB</gtr:id><gtr:name>Porvair Filtration Group Ltd</gtr:name><gtr:address><gtr:line1>Fareham Industrial Park</gtr:line1><gtr:line4>Fareham</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>PO16 8XG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/1529782F-9068-4364-888E-46E4FC4881F5"><gtr:id>1529782F-9068-4364-888E-46E4FC4881F5</gtr:id><gtr:name>Nottingham Trent University</gtr:name><gtr:department>School of Science &amp; Technology</gtr:department><gtr:address><gtr:line1>Burton Street</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG1 4BU</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1529782F-9068-4364-888E-46E4FC4881F5"><gtr:id>1529782F-9068-4364-888E-46E4FC4881F5</gtr:id><gtr:name>Nottingham Trent University</gtr:name><gtr:address><gtr:line1>Burton Street</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG1 4BU</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/58BA3BFC-AB13-4C69-8805-D8E3977BB4F9"><gtr:id>58BA3BFC-AB13-4C69-8805-D8E3977BB4F9</gtr:id><gtr:name>Nano Products</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3E738724-57DB-4CBB-A956-1F7720D9E193"><gtr:id>3E738724-57DB-4CBB-A956-1F7720D9E193</gtr:id><gtr:name>Invitron</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2E17EDA5-15D9-492E-BBC9-96F9CFC3A3DB"><gtr:id>2E17EDA5-15D9-492E-BBC9-96F9CFC3A3DB</gtr:id><gtr:name>Porvair Filtration Group Ltd</gtr:name><gtr:address><gtr:line1>Fareham Industrial Park</gtr:line1><gtr:line4>Fareham</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>PO16 8XG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C0071E5A-5B22-4BB1-B2F1-D008112EFB27"><gtr:id>C0071E5A-5B22-4BB1-B2F1-D008112EFB27</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Stevens</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1ADC3C99-7C56-4484-B727-5FDF395BE3DF"><gtr:id>1ADC3C99-7C56-4484-B727-5FDF395BE3DF</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Weeks</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=ST%2FK001892%2F1"><gtr:id>5A80A565-5AC0-40DE-8169-CED255A04E6E</gtr:id><gtr:title>Point-of-Care Chemiluminescent Diagnostic for 'early detection'of the predisposition to Type 2 diabetes.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>ST/K001892/1</gtr:grantReference><gtr:abstractText>Chemically induced light emission technology is being coupled to engineered nanoscale structures to create a unique type of sensor which is so sensitive and so specific that it will be able to measure extremely low levels of disease markers in a blood sample. The molecules of interest for a proof of concept demostrator are those associated with Type 2 diabetes. The point-of-care diagnostic will allow a member of the public to determine whether they are likely to develop Type 2 Diabetic within the next 5 years of life. The user would be able to do this at home, at a pharmacist or under the supevision of their doctor. 

The key to the technology is the nanostructure and composition of a biosensing patch which can be produced in extremely large numbers at low cost by combining scale up techniques to make large sheets of the nanoscale material with extremely fast laser cutting processes which are able to cut channels which are only 10 micrometers wide.

The technology has the potential to be configured to measure panels of disease markers within a single blood spot sample, which has the potential to measure the severity of disease and determine how far the disease has progressed.

The high sensitivity and specificity of the diagnostic will allow early diagnososis of disease, which will lead to improved patient outcomes.

Other applications include environmental and food monitoring and anti-counterfeit.</gtr:abstractText><gtr:potentialImpactText>The global population will be beneficiaries of the diagnostic due to increased numbers enjoying life long health and well being. Directly by delaying the onset of Type 2 diabetes by changing lifestyle and diet and increasing exercise. Indirectly, due to an increased expenditure directed towards treating other diseases due to the savings made by reducing the prevalence of Type 2. For example if widespread home screening for the predisposition of Type 2 resulted in the prevalence of Type 2 in the Uk being reduced by 10%. This would be a saving to the NHS of approximately &amp;pound;1Billion per annum. These savings could be passed on or redirected to treat other diseases. With modest investment and exploitation of existing supply chains and technical resources the impact could be realised within 3 to 5 years. 

The project aims to bring the performance of laboratory based chemiluminecent assays to the point-of-care and home user setting. Type 2 diabetes is the focus of our Proof-of-Concept demonstartor, but the technology can be translated to other disease types, including HIV, Alzheimers, and Cardiac.

We have identified a UK supply chain with capabilities suitable to manufacture, distribute and market the diagnostic device. (see Pathways to Impact document). It is expected that these companies will benefit due to increased turnover and profit. 

Global health care providers would be users of the platform technology, whether during the diagnosis of disease or as a companion diagnostic for selecting effective phamaceutricals by stratifying patients. 

We have received interest from Biocell International an Alere company which is the worlds leading point of care diagnostic company. GE Lifesciences have identified opportunities for a prescreening diagnostic for PET imaging. We believe Big Pharma would be interested in companion diagnostics which have extremely high sensitivity and selectivity, since this could provide opportunities to capitalise on their clinical assetswhich have failed trials due to non-stratified patient groups during clinical trials.

Outside human healthcare, the diagnostic could be used for veterinary science, anti-counterfeit, and environmental monitoring. 

We have won funds from NISCHR (National institute for Social Care and Health Research) which is a department of the Welsh government. They have peer reviewed the technology and funded &amp;pound;42k towards the work to be undertaken by Cardiff University. NISCHR are in a position to inform government of new technologies with economic and societal and environmental impact.

Staff working on the project will develop skills to create novel materials by electrospinning and develop network links to a range of device manufacturers and highly technical process providers.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-02-13</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/D7F4F462-0518-4784-908A-D12633C139B3"><gtr:id>D7F4F462-0518-4784-908A-D12633C139B3</gtr:id><gtr:name>STFC</gtr:name></gtr:funder><gtr:start>2012-11-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>48736</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Invitron</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Team to commercialise POC diagnostic</gtr:description><gtr:id>650C46C9-A4F1-44EF-B3FD-A590A2A88FC5</gtr:id><gtr:impact>Prrof of Concept</gtr:impact><gtr:outcomeId>58af6a7288f995.00096668-2</gtr:outcomeId><gtr:partnerContribution>Conversion to suitable structures. Manufacture of probes</gtr:partnerContribution><gtr:piContribution>Electrospinning of Nanofibre materials</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nano Products</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Nanofibre deposition</gtr:description><gtr:id>8CE908B5-F3EC-4ADC-B412-20736A2F4690</gtr:id><gtr:impact>Follow on grant applications to STFC</gtr:impact><gtr:outcomeId>5485a63d17f400.49896957-1</gtr:outcomeId><gtr:partnerContribution>Supply of bespoke substrate materials</gtr:partnerContribution><gtr:piContribution>Deposition of nanofibre mats onto perforated flexible substrate materials</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Cardiff University, School of Medicine</gtr:description><gtr:id>C8BA6E37-B4DE-47D5-BDA2-63B67B69F4BF</gtr:id><gtr:impact>Multi disciplinary.
Development of Nanofibe materials and associated processing technology.
Protocols to label nanofibre materials with Chemiluminescent probes</gtr:impact><gtr:outcomeId>iFgr2PC2477-1</gtr:outcomeId><gtr:partnerContribution>Development of Chemiluminescent protocols</gtr:partnerContribution><gtr:piContribution>Collaborative Research between the Material Science capability at iSMART, School of Science and Technology at Nottingham Trent University and the Department of Biochemistry at Cardiff Medical school.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Porvair Filtration Group Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Diagnostic well plate assembly</gtr:description><gtr:id>0CFF39C7-E76C-4DBF-8965-D3D64F4F93AA</gtr:id><gtr:impact>Participation in a follow on project.</gtr:impact><gtr:outcomeId>5485a54a84a730.80354085-1</gtr:outcomeId><gtr:partnerContribution>Ultrasonic welding of well plate bases to well plate trays.</gtr:partnerContribution><gtr:piContribution>Development of a nanofibre coating process which is compatible with plastic welding</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nano Products</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Team to commercialise POC diagnostic</gtr:description><gtr:id>CFFDDFE4-54D6-4BAC-BDB7-7573EFC5D396</gtr:id><gtr:impact>Prrof of Concept</gtr:impact><gtr:outcomeId>58af6a7288f995.00096668-1</gtr:outcomeId><gtr:partnerContribution>Conversion to suitable structures. Manufacture of probes</gtr:partnerContribution><gtr:piContribution>Electrospinning of Nanofibre materials</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Invitron</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Chemiluminescent probes</gtr:description><gtr:id>DED47F4D-FC09-4331-A861-1C4BF3730106</gtr:id><gtr:impact>Proof of concept has been achieved for a new Point of Care diagnostic</gtr:impact><gtr:outcomeId>5485a6fdeaa9a4.08025603-1</gtr:outcomeId><gtr:partnerContribution>Supply of chemiluminescent probes</gtr:partnerContribution><gtr:piContribution>Development and fabrication of nanofibre materials</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Meeting to discuss Innovate UK Health and Life Sciences proposal</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7F4F7431-DD32-4D18-9112-7563B4F98731</gtr:id><gtr:impact>Discussion to determine whether project proposal is in Scope to call</gtr:impact><gtr:outcomeId>58af677d4ac1a5.49495608</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>82663</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>STFC mini IPS</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>Science and Technologies Facilities Council (STFC)</gtr:fundingOrg><gtr:fundingRef>ST/M004244/1</gtr:fundingRef><gtr:id>7229B812-C3A7-4602-AB98-307CBE0A9051</gtr:id><gtr:outcomeId>56e13e2916fec8.17145510</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The outcomes of the research have been used as evidence to support a grant application into the STFC miniIPS programme to develop the point of care devices for early warning of the onset of type 2 diabetes. Also a bid has been submitted to the Wellcome Trust to develop a new would healing diagnostic</gtr:description><gtr:id>91BB9469-BA8B-41A9-94D6-F7BCC7E9B690</gtr:id><gtr:impactTypes/><gtr:outcomeId>5451f74021bb61.50455244</gtr:outcomeId></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have developed a bioactive nanomaterial fro a new type of medical diagnostic. Following a set of well defined protocols, the material is able to create a light signal, where the strength of the light is related to the likelihood of a person developing Type 2 diabetes.</gtr:description><gtr:exploitationPathways>The technology could be applied in a clinical laboratory for screening patients blood samples or could be packaged into a new type of point of care diagnostic for self test or in primary care settings.

The technology could be developed for anti-counterfeiting of materials, road side drug tests and environmental monitoring.</gtr:exploitationPathways><gtr:id>C38FE3A1-0628-48E9-AEE3-24F311C4C4F8</gtr:id><gtr:outcomeId>5451f676d5d047.97463135</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Chemicals,Environment,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Self built electrospinning system for the production of non-woven and aligned nanofibre materials. Supported by additional funding from Nottingham trent University</gtr:description><gtr:id>9B90DB7F-CB98-4DFC-9250-BDEC78CBCD9D</gtr:id><gtr:impact>Eleectrospun materials being investigated for novel Solar Sterilisation Techynology for clean safe water</gtr:impact><gtr:outcomeId>EpKUTiZ72f1</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Electrospinning System</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.ntu.ac.uk\iSMART</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">ST/K001892/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>F95121C7-7C31-40CE-BDBC-1E2BF025AEA6</gtr:id><gtr:percentage>5</gtr:percentage><gtr:text>Energy</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>D513F43E-F19D-4AB3-8E03-A47B085709AB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Materials Processing</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>E847DD9B-2053-4BC7-97A9-4213B185C968</gtr:id><gtr:percentage>35</gtr:percentage><gtr:text>Materials sciences</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>D22AE401-1C35-4706-A19C-10861ABC82CD</gtr:id><gtr:percentage>10</gtr:percentage><gtr:text>Biological membranes</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>BD108981-2A72-4C45-AAC2-425461EB90BE</gtr:id><gtr:percentage>5</gtr:percentage><gtr:text>Biomaterials</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>EC4522D3-ABD6-432A-9268-0F772EA73CB9</gtr:id><gtr:percentage>5</gtr:percentage><gtr:text>Fuel Cell Technologies</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>D513F43E-F19D-4AB3-8E03-A47B085709AB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Materials Processing</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>063026C5-CD0B-48AB-82F3-6359499A95D4</gtr:id><gtr:percentage>30</gtr:percentage><gtr:text>Materials Synthesis &amp; Growth</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>